Aurora Therapeutics' first target is the rare inherited disease phenylketonuria, also known as PKU. Here at MIT Technology Review we’ve been writing about the gene-editing technology CRISPR since 2013 ...

Proteins produced by RNA segments can aid in the repair of damaged neurons in human bodies. However, in neurological conditions like ALS and spinal muscular atrophy, or after spinal cord injuries, the ...

Dr. Hong Li, professor in Van Andel Institute’s Department of Structural Biology, leverages CRISPR, cryo-EM and other leading-edge technologies to explore the mechanisms underlying RNA-mediated ...

Plus: Grok is restricting its image-generating function to paid subscribers only This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the ...

CRISPR–Cas9-based therapies are widely investigated for their clinical applications. However, there are limitations associated with the strategy, including off-target DNA editing. A group of ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA regulatory pathway to commercialize treatments for rare diseases. Last February ...

BOSTON--(BUSINESS WIRE)--Aurora Therapeutics today announced its official launch to transform personalized gene editing from a one-patient breakthrough into a scalable model capable of bringing ...

Check out these events in Palm Beach and vicinity related to the home and garden in our weekly Home & Loggia Calendar.

So you're minding your own business, using Windows as you've been forever, and suddenly a Linux enthusiast discovers you're not running Arch with a tiling window manager. Then, they dish out the usual ...